{"id":"W2597980661","doi":"10.1200/jco.2017.35.4_suppl.tps814","title":"Utilizing total neoadjuvant therapy (TNT) in rectal cancer: NRG-GI002, a phase II clinical trial platform.","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Colorectal Cancer Surgical Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Capecitabine; Colorectal cancer; Neoadjuvant therapy; Clinical endpoint; Total mesorectal excision; Oncology; FOLFOX; Population; Internal medicine; Chemoradiotherapy; Radiation therapy; Randomized controlled trial; Cancer; Surgery; Oxaliplatin; Breast cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004230537,0.0013611,0.0009534649,0.0005035868,0.000298499,0.0009068608,0.001026316,0.001310563,0.006529051],"category_scores_gemma":[0.001737612,0.0004751572,0.001007744,0.0005058383,0.0009786683,0.0006812296,0.0007732781,0.002397194,0.001228498],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006693852,"about_ca_system_score_gemma":0.003261786,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006033021,"about_ca_topic_score_gemma":0.002259883,"domain_scores_codex":[0.9992738,0.000451514,0.00002862121,0.00008158643,0.00007035704,0.00009407345],"domain_scores_gemma":[0.9989983,0.0001364383,0.0002645311,0.0001141826,0.00006418195,0.0004222977],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6971108,0.06197983,0.005610472,0.002044243,0.001015305,0.0003015608,0.0002996688,0.004392942,0.06133086,0.001526306,0.01637832,0.1480096],"study_design_scores_gemma":[0.6087419,0.3746455,0.004785861,0.00008970516,0.0003005375,0.000249384,0.00005116489,0.001494431,0.00312048,0.0005430662,0.005950738,0.00002718435],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9467999,0.002997163,0.004464318,0.002409818,0.0003883682,0.0296713,0.006152295,0.0006562538,0.006460676],"genre_scores_gemma":[0.8850932,0.003316191,0.02264614,0.003943477,0.0003632593,0.06399968,0.01098448,0.0001813002,0.009472327],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006529051,"threshold_uncertainty_score":0.0223735,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.4656506032312347,"score_gpt":0.609232623020844,"score_spread":0.1435820197896093,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}